Items where authors include "Tsatsanis, A"

Article

Lewis, FW, Bird, K, Navarro, J-P et al. (9 more authors) (2022) Synthesis, physicochemical characterization and neuroprotective evaluation of novel 1-hydroxypyrazin-2(1H)-one iron chelators in an in vitro cell model of Parkinson's disease. Dalton Transactions, 51 (9). pp. 3590-3603. ISSN 1477-9226

Tsatsanis, A, McCorkindale, AN, Wong, BX et al. (8 more authors) (2021) The acute phase protein lactoferrin is a key feature of Alzheimer's disease and predictor of A beta burden through induction of APP amyloidogenic processing. Molecular Psychiatry, 26. pp. 5516-5531. ISSN 1359-4184

Tsatsanis, A, Dickens, S, Kwok, JCF orcid.org/0000-0002-9798-9083 et al. (2 more authors) (2019) Post Translational Modulation of β-Amyloid Precursor Protein Trafficking to the Cell Surface Alters Neuronal Iron Homeostasis. Neurochemical Research, 44 (6). pp. 1367-1374. ISSN 0364-3190

Lopez Sanchez, MIG, Waugh, HS, Tsatsanis, A et al. (4 more authors) (2017) Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta. Scientific Reports, 7 (1). 9835. ISSN 2045-2322

Workman, DG, Tsatsanis, A, Lewis, FW et al. (7 more authors) (2015) Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators. Metallomics, 7 (5). 867 - 876. ISSN 1756-5901